FOLLICULAR LYMPHOMA FOUNDATION US INC (EIN 842338899) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2019

Legal Domicile

Principal Officer

JONATHAN COHEN

Phone

5187635580

Tax Period

2024-01-01 to 2024-12-31

FOLLICULAR LYMPHOMA FOUNDATION US INC, founded in 2019, is a small nonprofit in the Philanthropy & Grantmaking sector that reported $532K in total revenue in fiscal year 2024. Revenue surged 60% from the prior year, signaling strong growth momentum.

Mission

FUNDING OF RESEARCH TO FIND A CURE FOR FOLLICULAR LYMPHOMA

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $532,035

Program Service Revenue $0

Investment Income $0

Other Revenue $0

TOTAL REVENUE $532,035

Expense Breakdown

Grants Paid $0

Salaries & Benefits $440,955

Fundraising Expenses $0

Other Expenses $86,739

TOTAL EXPENSES $527,694

Year-over-Year Comparison

	2024	2023	Change
Revenue	$532,035	$333,392	+0.6%
Expenses	$527,694	$973,375	-0.5%
Net Income	$4,341	$-639,983	-1.0%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✗ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

N/A

Employees

Volunteers

N/A

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

$255,000

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
MATT SMITH	MEDICAL DIRECTOR	020.00	Key Emp	$255,000	$0	$255,000
NICOLA MENDELSOHN	PRESIDENT	N/A	Director	$0	$0	$0
JONATHAN COHEN	SECRETARY AND TREASURER	N/A	Director	$0	$0	$0
LOUIS DEGENNARO	BOARD MEMBER	N/A	Director	$0	$0	$0
CAROLYN NOEL EVERSON	BOARD MEMBER	N/A	Director	$0	$0	$0
FRANZ HUMER	BOARD MEMBER	N/A	Director	$0	$0	$0
JONATHAN SIMONS	BOARD MEMBER	N/A	Director	$0	$0	$0
JONATHAN NEIL MENDELSOHN	BOARD MEMBER	N/A	Director	$0	$0	$0
CAROLYN EVERSON	BOARD MEMBER	N/A	Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	$532,035	$527,694	$449,607	$4,341
2023	$333,392	$973,375	$1,103,673	$-639,983
2022	$1,117,500	$1,391,955	$1,069,715	$-274,455
2021	$2,172,175	$731,487	$1,468,845	$1,440,688
2021	$2,172,175	$855,237	$1,468,845	$1,316,938

FOLLICULAR LYMPHOMA FOUNDATION US INC